Skip to main content
OpenTrials

Clinical trial condition

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

Explore clinical trials studying Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia trial results

Completed

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

NCT04362813

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Glendale, California, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site San Francisco, California, United States
View all 39 locations
View Trial Details

Related conditions